MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Empathy in Action A Sensory Experience for Healthcare Providers

    K. Papesh, A. Mitchell, C. Pizzillo (Phoenix, USA)

    Objective: Evaluate the impact of a multisensory, hands-on experience designed to simulate the motor and non-motor symptoms of Parkinson’s disease (PD) on healthcare providers’ (HCPs)…
  • 2025 International Congress

    Effects of an Intensive Multidisciplinary Rehabilitation Program on Patients with Spinocerebellar Ataxia

    F. Coimbra, MC. da Cunha, J. Veloso, M. da Cunha, MR. Moreno, E. Mosimann, L. Siciliani, JR. Junior, J. Caetano, CE. Del Rio, C. Couto (Rio de Janeiro, Brazil)

    Objective: To evaluate the effectiveness of an intensive multidisciplinary rehabilitation program in patients with spinocerebellar ataxia. Background: Spinocerebellar ataxias (SCAs) cause significant motor impairment, affecting…
  • 2025 International Congress

    Digital balance and gait measures show promise to track progression of Friedreich’s ataxia

    V. Shah, D. Muzyka, H. Casey, J. Mcnames, M. El Gohary, K. Sowalsky, D. Safarpour, P. Carlson-Kuhta, J. Schmahmann, L. Rosenthal, S. Perlman, F. Horak, C. Gomez (Philadelphia, USA)

    Objective: This study aimed to identify balance and gait measures sensitive to disease progression in a multicenter clinical trial of Friedreich Ataxia (FRDA). Background: The…
  • 2025 International Congress

    Correlation of the FXTAS Staging System and the FXTAS Rating Scale

    D. Hall, B. Ouyang, M. Tosin (Chicago, USA)

    Objective: To determine correlation between the Fragile X-associated tremor ataxia syndrome (FXTAS) staging system and the FXTAS rating scale Background: FXTAS is an X-linked, neurodegenerative…
  • 2025 International Congress

    A mindfulness-based intervention course in pre-manifest Huntington’s disease: analysis of pilot data

    S. Berman, R. Devenyi, V. Vaughn, G. Toti, A. Lasker (Camden, USA)

    Objective: To assess feasibility and initial outcomes of a mindfulness-based intervention course in patients with pre-manifest, genetically confirmed Huntington’s disease (HD). Background: Mindfulness-based intervention courses…
  • 2025 International Congress

    Safety, Feasibility, and Effects of Time-Restricted Eating in Early-Stage Huntington’s Disease: Preliminary Analysis of a Clinical Pilot Trial

    R. Wells, L. Neilson, A. Hiller (Portland, USA)

    Objective: Evaluate whether 12 weeks of daily time-restricted eating (TRE) appears safe and feasible in persons with early-stage Huntington's disease (HD) and explore its effects…
  • 2025 International Congress

    Myorhythmia: A Quantitative Study of Synchrony and Rhythmicity Between The Head and Upper Limbs

    M. Elkhooly, A. El Kouzi, R. Elble (Springfield, USA)

    Objective: Examine the kinematic properties of the myorhythmia with quantitative motion analysis. Background: Myorhythmia is a rare form of tremor that is defined by a uniquely low…
  • 2025 International Congress

    Closed-Loop Electrical Stimulation Reduces Tremor and Decreases Tremorogenic Neural Drives in Essential Tremor: A Case Report

    X. Yu, N. Kurukuti, H. Hassanlouei, G. Hoo, E. Roth, J. Pons (Chicago, USA)

    Objective: To investigate the effectiveness of closed-loop sensory-specific peripheral electrical stimulation (CLS) in reducing tremor and modulating tremorogenic neural drive. Background: Sensory peripheral electrical stimulation…
  • 2025 International Congress

    Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study

    E. Dunayevich, A. Parameswaran, M. Bron, E. Franey, D. Sparta, C. Zeng, S. Mathias, J. Mcevoy (San Diego, USA)

    Objective: To evaluate the effects of once-daily valbenazine (VBZ) on the impacts of tardive dyskinesia (TD) using multiple patient-reported outcomes (PROs), including the psychometrically validated…
  • 2025 International Congress

    Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.

    MB. Charra Castellani, MV. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Evaluate the quality of life and the presence of anxiety and depression in HFS patients and their behavior after botulinum toxin administration. Background: Hemifacial…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley